N-Myc inhibitors belong to a class of chemical compounds that specifically target the N-Myc protein, a member of the Myc family of transcription factors. These inhibitors are designed to modulate the activity of the N-Myc protein, which plays a pivotal role in the regulation of various cellular processes, including cell growth, proliferation, and differentiation. The N-Myc protein is known to be involved in the control of gene expression, particularly those associated with cell cycle progression and cellular metabolism. N-Myc inhibitors operate by binding to the N-Myc protein, thereby influencing its interactions with other molecules within the cellular environment. By exerting this influence, these inhibitors aim to disrupt the normal function of N-Myc and consequently impact downstream signaling pathways that are orchestrated by the protein.
Structurally, N-Myc inhibitors vary in their chemical composition, often displaying diverse chemical scaffolds. The mode of action for these inhibitors typically involves competitive or allosteric binding to the N-Myc protein, altering its conformation and interfering with its ability to bind to DNA or other proteins. This disruption ultimately leads to the modulation of gene expression patterns, which can have profound effects on cellular behavior.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
10074-G5 | 413611-93-5 | sc-213578 sc-213578B sc-213578A sc-213578C sc-213578D | 5 mg 10 mg 25 mg 100 mg 1 g | $82.00 $154.00 $330.00 $982.00 $2045.00 | 3 | |
Inhibits N-Myc-Max heterodimerization and interferes with N-Myc's transcriptional activity. | ||||||
KJ Pyr 9 | 581073-80-5 | sc-507276 | 5 mg | $140.00 | ||
Disrupts N-Myc's interaction with the BRD4 protein, leading to decreased transcriptional activation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Affects N-Myc expression by targeting the BET family of bromodomain proteins. | ||||||
THZ1 | 1604810-83-4 | sc-507542 | 1 mg | $95.00 | ||
Blocks CDK7, inhibiting CDK7-mediated phosphorylation of N-Myc and downregulating its activity. | ||||||
3-[(3-Methoxybenzoyl)amino]-4-(4-methyl-1-piperazinyl)benzoic acid methyl ester-d3 | 890190-22-4 (unlabeled) | sc-484812 | 1 mg | $380.00 | ||
Disrupts the interaction between N-Myc and WDR5, leading to reduced transcriptional activation. | ||||||